These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 27396428)

  • 21. Clinical evaluation of demineralized freeze-dried bone allograft with and without enamel matrix derivative for the treatment of periodontal osseous defects in humans.
    Hoidal MJ; Grimard BA; Mills MP; Schoolfield JD; Mellonig JT; Mealey BL
    J Periodontol; 2008 Dec; 79(12):2273-80. PubMed ID: 19053917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet-Rich Fibrin Combined With a Porous Hydroxyapatite Graft for the Treatment of 3-Wall Intrabony Defects in Chronic Periodontitis: A Randomized Controlled Clinical Trial.
    Pradeep AR; Bajaj P; Rao NS; Agarwal E; Naik SB
    J Periodontol; 2017 Dec; 88(12):1288-1296. PubMed ID: 29314065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of enamel matrix derivative with freeze-dried bone allograft or demineralized freeze-dried bone allograft in intrabony defects: a randomized trial.
    Ogihara S; Tarnow DP
    J Periodontol; 2014 Oct; 85(10):1351-60. PubMed ID: 24660759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and radiographic evaluation and comparison of bioactive bone alloplast morsels when used alone and in combination with platelet-rich fibrin in the treatment of periodontal intrabony defects-A randomized controlled trial.
    Bodhare GH; Kolte AP; Kolte RA; Shirke PY
    J Periodontol; 2019 Jun; 90(6):584-594. PubMed ID: 30488952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of postsurgical administration of a selective cyclo-oxygenase-2 inhibitor on the healing of intrabony defects following treatment with enamel matrix proteins.
    Sculean A; Berakdar M; Donos N; Auschill TM; Arweiler NB
    Clin Oral Investig; 2003 Jun; 7(2):108-12. PubMed ID: 12720115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a β-tricalcium phosphate.
    Döri F; Arweiler NB; Szántó E; Agics A; Gera I; Sculean A
    J Periodontol; 2013 Jun; 84(6):749-57. PubMed ID: 22873657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A clinical comparison of a bovine-derived xenograft used alone and in combination with enamel matrix derivative for the treatment of periodontal osseous defects in humans.
    Scheyer ET; Velasquez-Plata D; Brunsvold MA; Lasho DJ; Mellonig JT
    J Periodontol; 2002 Apr; 73(4):423-32. PubMed ID: 11990444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet-rich fibrin with 1% metformin for the treatment of intrabony defects in chronic periodontitis: a randomized controlled clinical trial.
    Pradeep AR; Nagpal K; Karvekar S; Patnaik K; Naik SB; Guruprasad CN
    J Periodontol; 2015 Jun; 86(6):729-37. PubMed ID: 25762357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcomes after treatment of non-contained intrabony defects with enamel matrix derivative or guided tissue regeneration: a 12-month randomized controlled clinical trial.
    Siciliano VI; Andreuccetti G; Siciliano AI; Blasi A; Sculean A; Salvi GE
    J Periodontol; 2011 Jan; 82(1):62-71. PubMed ID: 20809859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of clinical, radiographic, and histometric measurements following treatment with guided tissue regeneration or enamel matrix proteins in human periodontal defects.
    Windisch P; Sculean A; Klein F; Tóth V; Gera I; Reich E; Eickholz P
    J Periodontol; 2002 Apr; 73(4):409-17. PubMed ID: 11990442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjunctive Effect of Autologus Platelet-Rich Fibrin to Barrier Membrane in the Treatment of Periodontal Intrabony Defects.
    Panda S; Sankari M; Satpathy A; Jayakumar D; Mozzati M; Mortellaro C; Gallesio G; Taschieri S; Del Fabbro M
    J Craniofac Surg; 2016 May; 27(3):691-6. PubMed ID: 27046472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet-Rich Fibrin Combined With 1.2% Atorvastatin for Treatment of Intrabony Defects in Chronic Periodontitis: A Randomized Controlled Clinical Trial.
    Martande SS; Kumari M; Pradeep AR; Singh SP; Suke DK; Guruprasad CN
    J Periodontol; 2016 Sep; 87(9):1039-46. PubMed ID: 27294433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of intrabony defects with an enamel matrix protein derivative or bioabsorbable membrane: an 8-year follow-up split-mouth study.
    Sculean A; Schwarz F; Miliauskaite A; Kiss A; Arweiler N; Becker J; Brecx M
    J Periodontol; 2006 Nov; 77(11):1879-86. PubMed ID: 17076614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of gingival crevicular fluid transforming growth factor-β1 level after treatment of intrabony periodontal defects with enamel matrix derivatives and autogenous bone graft: A randomized controlled clinical trial.
    Agrali ÖB; Kuru BE; Yarat A; Kuru L
    Niger J Clin Pract; 2016; 19(4):535-43. PubMed ID: 27251974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enamel matrix derivative in intrabony defects: prognostic parameters of clinical and radiographic treatment outcomes.
    Parashis AO; Polychronopoulou A; Tsiklakis K; Tatakis DN
    J Periodontol; 2012 Nov; 83(11):1346-52. PubMed ID: 22248222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Five-year clinical and histologic results following treatment of human intrabony defects with an enamel matrix derivative combined with a natural bone mineral.
    Sculean A; Chiantella GC; Arweiler NB; Becker J; Schwarz F; Stavropoulos A
    Int J Periodontics Restorative Dent; 2008 Apr; 28(2):153-61. PubMed ID: 18546811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term follow-up and tomographic assessment of an intrabony defect treated with enamel matrix derivative.
    Bhatavadekar NB; Paquette DW
    J Periodontol; 2008 Sep; 79(9):1802-8. PubMed ID: 18771385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative evaluation of autologous platelet-rich fibrin and platelet-rich plasma in the treatment of 3-wall intrabony defects in chronic periodontitis: a randomized controlled clinical trial.
    Pradeep AR; Rao NS; Agarwal E; Bajaj P; Kumari M; Naik SB
    J Periodontol; 2012 Dec; 83(12):1499-507. PubMed ID: 22348695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Papilla preservation technique combined with Emdogain in the treatment of intrabony defects: a novel treatment regimen for chronic periodontitis.
    Miliauskaite A; Selimovic D; Hassan M; Nagano F; Soell M; Sano H; Puriene A
    Stomatologija; 2008; 10(1):22-6. PubMed ID: 18493162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and radiographic evaluation of platelet-rich fibrin and bone graft material (β-tricalcium phosphate + hydroxyapatite) in the treatment of intrabony defects of periodontitis patients: a randomized controlled trial.
    Baghele O; Thorat M; Malpani P
    Quintessence Int; 2023 Jun; 54(6):472-483. PubMed ID: 36825719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.